Ergoteles’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-36,900
Closed -$225K 1777
2021
Q3
$225K Buy
+36,900
New +$230K 0.01% 929

Ergoteles's FLXN Position: Q4 2021 in Review

Ergoteles sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 36,900 shares — an estimated $225K sold.

Ergoteles first reported a position in FLXN in Q3 2021 and held it in 1 quarter. The position peaked at $225K in Q3 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

  • Ergoteles reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Ergoteles sold 36,900 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $225K.
  • Ergoteles first reported a position in Flexion Therapeutics, Inc. in Q3 2021 and held it in 1 quarter.
  • Ergoteles's Flexion Therapeutics, Inc. position peaked at $225K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.